Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH(TM) Drug Delivery Technology Finding Multiple Medical Applications

Lexaria intends to undertake its most ambitious study yet – HYPER-H21-4 – as it pursues regulatory approval for DehydraTECH-CBD for potential use as a treatment for hypertension HYPER-H21-4 will build on successes witnessed in initial human hypertension studies The company, which has a fully funded R&D budget, recently announced new R&D programs covering multiple conditions, […]

NECANN – The Illinois Cannabis Convention Comes to Chicago

Date: December 4-5, 2021 Venue: Chicago Hilton, 720 South Michigan Ave, Chicago, IL Exhibit Hall Hours Saturday, December 4th: 11:00 A.M. to 5:00 P.M. Sunday, December 5th: 10:00 A.M. to 4:00 P.M. Onsite Box Office hours begin at 9:00 a.m. each day. Cannabis cultivators, dealers, businesses, and enthusiasts are invited to attend the NECANN Illinois […]

Simply Sonoma Inc. Developing High-Quality, All-Natural CBD-Infused Beverages for Entry into Growing Market

CBD-infused beverages market expected to make over $14,600 million by the end of 2026 CBD beverages are becoming more popular as cannabis-infused goods become legalized across the United States and around the world Simply Sonoma has two CBD-infused beverages on the docket: an alcohol-free, CBD wine product and a low-carb, low-sugar CBD sparkling product Cannabidiol, or […]

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Adding to its Growing Retail Presence with Rapid Developments in Florida

Red White & Bloom Brands is building a multi-state operation in the cannabis and hemp industries through state subsidiaries focused on markets in Florida, Michigan, Illinois, Arizona and California The company is now rapidly building up its cultivation and retail operations in Florida, advancing from regulatory approval in the state last month to the startup […]

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Launches Global Bitcoin Lightning Network Platform

LQwD’s proprietary, multi-pronged Lightning Network platform provides easier access to a decentralized network and payment solution The platform makes it possible for users to create and manage Lightning Network nodes easily; make transactions securely, privately, and almost instantaneous; create channels on the Network with effective routing; request and manage liquidity more efficiently Bitcoin experts have […]

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Updating Trial Protocols in Response to FDA Request as Tryp Prepares Synthetic Psilocybin Studies for Eating Disorder, Fibromyalgia Treatment

Pharmaceutical company Tryp Therapeutics is investigating the potential of synthetic psychedelic drug candidates to treat unmet medical needs The company is evaluating two drug products labeled TRP-8802 and TRP-8803 for treating fibromyalgia, phantom limb pain, complex regional pain syndrome and select eating disorders The company has filed its first two INDs with the FDA for […]

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Excited for Seamless Phase 2/3 Clinical Research as Dr. Matthew Johnson Presents Interim Results of Current Smoking Cessation Study at the Psychedelic Medicine Business Event: Wonderland

Dr. Matthew Johnson discussed psilocybin for tobacco smoking cessation at this year’s Psychedelic Medicine Business Event: Wonderland, in Miami He shared preliminary findings from his recent study on substance use disorder, along with the participants’ feedback on their experience Dr. Johnson, along with Mydecine, are set to embark on their clinical study utilizing MYCO-001 for […]

 

From Our Blog

HeartBeam Inc. (NASDAQ: BEAT) Advances Remote Cardiac Diagnostics with HeartNexus Partnership

November 13, 2025

HeartBeam (NASDAQ: BEAT), a medical-technology company developing next-generation cardiac diagnostics via its patented 12-Lead ECG synthesis software, has announced a strategic collaboration with HeartNexus (https://ibn.fm/yyz1i). The partnership will expand access to cardiologist-level ECG insights for arrhythmia assessment anytime, anywhere. Cardiovascular disease remains the leading cause of mortality worldwide, responsible for an estimated 17.9 million deaths […]

Rotate your device 90° to view site.